| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome J Galon, A Costes, F Sanchez-Cabo, A Kirilovsky, B Mlecnik, ... Science 313 (5795), 1960-1964, 2006 | 6128 | 2006 |
| ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks G Bindea, B Mlecnik, H Hackl, P Charoentong, M Tosolini, A Kirilovsky, ... Bioinformatics 25 (8), 1091-1093, 2009 | 4516 | 2009 |
| The immune contexture in human tumours: impact on clinical outcome WH Fridman, C Sautès-Fridman, J Galon Nature Reviews Cancer 12 (4), 298-306, 2012 | 3949 | 2012 |
| Effector memory T cells, early metastasis, and survival in colorectal cancer F Pagès, A Berger, M Camus, F Sanchez-Cabo, A Costes, R Molidor, ... New England journal of medicine 353 (25), 2654-2666, 2005 | 2245 | 2005 |
| Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer G Bindea, B Mlecnik, M Tosolini, A Kirilovsky, M Waldner, AC Obenauf, ... Immunity 39 (4), 782-795, 2013 | 2119 | 2013 |
| The immune contexture in cancer prognosis and treatment WH Fridman, L Zitvogel, C Sautès–Fridman, G Kroemer Nature reviews Clinical oncology 14 (12), 717-734, 2017 | 1224 | 2017 |
| Immune infiltration in human tumors: a prognostic factor that should not be ignored J Galon, MC Dieu-Nosjean, E Tartour, C Sautes-Fridman, WH Fridman Oncogene 29 (8), 1093-1102, 2010 | 1136 | 2010 |
| Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression E Becht, NA Giraldo, L Lacroix, B Buttard, N Elarouci, F Petitprez, J Selves, ... Genome biology 17 (1), 1-20, 2016 | 1127 | 2016 |
| Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal CancerOpposite Clinical Impact of Th1 and … M Tosolini, A Kirilovsky, B Mlecnik, T Fredriksen, S Mauger, G Bindea, ... Cancer research 71 (4), 1263-1271, 2011 | 1098 | 2011 |
| Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction B Mlecnik, M Tosolini, A Kirilovsky, A Berger, G Bindea, T Meatchi, ... Journal of clinical oncology 29 (6), 610-618, 2011 | 973 | 2011 |
| In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer F Pagès, A Kirilovsky, B Mlecnik, M Asslaber, M Tosolini, G Bindea, ... Journal of clinical oncology 27 (35), 5944-5951, 2009 | 969 | 2009 |
| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 895 | 2020 |
| Long-term survival for patients with non–small-cell lung cancer with intratumoral lymphoid structures MC Dieu-Nosjean, M Antoine, C Danel, D Heudes, M Wislez, V Poulot, ... Journal of Clinical Oncology 26 (27), 4410-4417, 2008 | 842 | 2008 |
| B cells are associated with survival and immunotherapy response in sarcoma F Petitprez, A de Reyniès, EZ Keung, TWW Chen, CM Sun, J Calderaro, ... Nature 577 (7791), 556-560, 2020 | 756 | 2020 |
| Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers C Badoual, S Hans, J Rodriguez, S Peyrard, C Klein, NEH Agueznay, ... Clinical cancer research 12 (2), 465-472, 2006 | 620 | 2006 |
| PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck CancerPD-1–Expressing T Cells in HPV-Associated Oral Cancers C Badoual, S Hans, N Merillon, C Van Ryswick, P Ravel, N Benhamouda, ... Cancer research 73 (1), 128-138, 2013 | 608 | 2013 |
| Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes S Amigorena, C Bonnerot, JR Drake, D Choquet, W Hunziker, JG Guillet, ... Science 256 (5065), 1808-1812, 1992 | 559 | 1992 |
| Anti–factor H autoantibodies associated with atypical hemolytic uremic syndrome MA Dragon-Durey, C Loirat, S Cloarec, MA Macher, J Blouin, H Nivet, ... Journal of the American Society of Nephrology 16 (2), 555-563, 2005 | 528 | 2005 |
| The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation M Daëron, S Latour, O Malbec, E Espinosa, P Pina, S Pasmans, ... Immunity 3 (5), 635-646, 1995 | 526 | 1995 |
| Tertiary lymphoid structures in the era of cancer immunotherapy C Sautès-Fridman, F Petitprez, J Calderaro, WH Fridman Nature Reviews Cancer 19 (6), 307-325, 2019 | 524 | 2019 |
